| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | intermediate filament organization | 1.82e-05 | 75 | 89 | 5 | GO:0045109 | |
| GeneOntologyBiologicalProcess | neuromuscular process | 5.40e-05 | 225 | 89 | 7 | GO:0050905 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 6.94e-05 | 99 | 89 | 5 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 7.28e-05 | 100 | 89 | 5 | GO:0045103 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 1.82e-06 | 263 | 89 | 9 | GO:0045111 | |
| GeneOntologyCellularComponent | hemidesmosome | 1.20e-05 | 11 | 89 | 3 | GO:0030056 | |
| GeneOntologyCellularComponent | intermediate filament | 5.26e-05 | 227 | 89 | 7 | GO:0005882 | |
| GeneOntologyCellularComponent | supramolecular fiber | DLGAP2 KRT26 HABP4 MYH10 EPPK1 KRT16 XIRP2 KRT19 AMOT SYNE2 NCKIPSD CAPZB TOGARAM1 PLEC SMTN | 1.27e-04 | 1179 | 89 | 15 | GO:0099512 |
| GeneOntologyCellularComponent | sarcoplasm | 1.27e-04 | 114 | 89 | 5 | GO:0016528 | |
| GeneOntologyCellularComponent | supramolecular polymer | DLGAP2 KRT26 HABP4 MYH10 EPPK1 KRT16 XIRP2 KRT19 AMOT SYNE2 NCKIPSD CAPZB TOGARAM1 PLEC SMTN | 1.37e-04 | 1187 | 89 | 15 | GO:0099081 |
| GeneOntologyCellularComponent | actin cytoskeleton | 1.68e-04 | 576 | 89 | 10 | GO:0015629 | |
| GeneOntologyCellularComponent | cell-substrate junction | 6.03e-04 | 443 | 89 | 8 | GO:0030055 | |
| GeneOntologyCellularComponent | sarcomere | 6.85e-04 | 249 | 89 | 6 | GO:0030017 | |
| GeneOntologyCellularComponent | anchoring junction | EPPK1 MAPK15 XIRP2 AMOT CAPN1 SYNE2 DDR2 LAMA3 ANO7 TLN2 PKN2 PLEC | 8.66e-04 | 976 | 89 | 12 | GO:0070161 |
| GeneOntologyCellularComponent | dendrite | DLGAP2 MYH10 RAP1GAP SACS PPFIA2 LRFN3 CAPZB XRN1 PLEC SCGN ITPR1 | 1.03e-03 | 858 | 89 | 11 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | DLGAP2 MYH10 RAP1GAP SACS PPFIA2 LRFN3 CAPZB XRN1 PLEC SCGN ITPR1 | 1.05e-03 | 860 | 89 | 11 | GO:0097447 |
| GeneOntologyCellularComponent | myofibril | 1.10e-03 | 273 | 89 | 6 | GO:0030016 | |
| GeneOntologyCellularComponent | post-mRNA release spliceosomal complex | 1.15e-03 | 12 | 89 | 2 | GO:0071014 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.50e-03 | 290 | 89 | 6 | GO:0043292 | |
| MousePheno | postnatal lethality, incomplete penetrance | GPI MYH10 KRT16 SMC3 SPEF2 BRD4 SPTB SREBF1 NPAS3 UBR3 ZFHX3 XPNPEP1 ITPR1 SMTN | 7.74e-06 | 669 | 73 | 14 | MP:0011086 |
| MousePheno | postnatal lethality | GPI MYH10 KRT16 SMC3 XIRP2 SPEF2 BRD4 SPTB SREBF1 NPAS3 LAMA3 UBR3 ZFHX3 IRS1 XPNPEP1 PLEC ITPR1 SMTN | 8.15e-06 | 1084 | 73 | 18 | MP:0002082 |
| Domain | CH | 2.69e-05 | 73 | 90 | 5 | PS50021 | |
| Domain | CH-domain | 3.07e-05 | 75 | 90 | 5 | IPR001715 | |
| Domain | Actinin_actin-bd_CS | 1.79e-04 | 23 | 90 | 3 | IPR001589 | |
| Domain | PAS_fold_3 | 1.79e-04 | 23 | 90 | 3 | IPR013655 | |
| Domain | PAS_3 | 1.79e-04 | 23 | 90 | 3 | PF08447 | |
| Domain | ACTININ_2 | 1.79e-04 | 23 | 90 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.79e-04 | 23 | 90 | 3 | PS00019 | |
| Domain | PAS-assoc_C | 2.04e-04 | 24 | 90 | 3 | IPR000700 | |
| Domain | - | 2.27e-04 | 5 | 90 | 2 | 1.10.287.160 | |
| Domain | PAS | 2.30e-04 | 25 | 90 | 3 | PF00989 | |
| Domain | PAS_fold | 2.30e-04 | 25 | 90 | 3 | IPR013767 | |
| Domain | PAC | 2.60e-04 | 26 | 90 | 3 | IPR001610 | |
| Domain | PAC | 2.60e-04 | 26 | 90 | 3 | SM00086 | |
| Domain | PAC | 2.60e-04 | 26 | 90 | 3 | PS50113 | |
| Domain | CH | 2.73e-04 | 65 | 90 | 4 | SM00033 | |
| Domain | - | 3.40e-04 | 6 | 90 | 2 | 3.90.1290.10 | |
| Domain | Spectrin_repeat | 3.61e-04 | 29 | 90 | 3 | IPR002017 | |
| Domain | CH | 3.63e-04 | 70 | 90 | 4 | PF00307 | |
| Domain | - | 3.83e-04 | 71 | 90 | 4 | 1.10.418.10 | |
| Domain | Plectin_repeat | 4.75e-04 | 7 | 90 | 2 | IPR001101 | |
| Domain | Hr1 | 4.75e-04 | 7 | 90 | 2 | SM00742 | |
| Domain | Plectin | 4.75e-04 | 7 | 90 | 2 | PF00681 | |
| Domain | SIX1_SD | 4.75e-04 | 7 | 90 | 2 | PF16878 | |
| Domain | SIX1_SD | 4.75e-04 | 7 | 90 | 2 | IPR031701 | |
| Domain | PLEC | 4.75e-04 | 7 | 90 | 2 | SM00250 | |
| Domain | Spectrin/alpha-actinin | 4.85e-04 | 32 | 90 | 3 | IPR018159 | |
| Domain | PAS | 4.85e-04 | 32 | 90 | 3 | SM00091 | |
| Domain | SPEC | 4.85e-04 | 32 | 90 | 3 | SM00150 | |
| Domain | PAS | 5.81e-04 | 34 | 90 | 3 | IPR000014 | |
| Domain | PAS | 5.81e-04 | 34 | 90 | 3 | PS50112 | |
| Domain | HR1 | 6.31e-04 | 8 | 90 | 2 | PF02185 | |
| Domain | Keratin_I | 1.24e-03 | 44 | 90 | 3 | IPR002957 | |
| Domain | Ankyrin_rpt | 1.68e-03 | 262 | 90 | 6 | IPR002110 | |
| Domain | - | 1.91e-03 | 109 | 90 | 4 | 4.10.280.10 | |
| Domain | IRS_PTB | 2.01e-03 | 14 | 90 | 2 | IPR002404 | |
| Domain | IRS | 2.01e-03 | 14 | 90 | 2 | PF02174 | |
| Domain | HLH | 2.04e-03 | 111 | 90 | 4 | PF00010 | |
| Domain | HLH | 2.39e-03 | 116 | 90 | 4 | SM00353 | |
| Domain | BHLH | 2.47e-03 | 117 | 90 | 4 | PS50888 | |
| Domain | bHLH_dom | 2.55e-03 | 118 | 90 | 4 | IPR011598 | |
| Domain | Ank_2 | 3.84e-03 | 215 | 90 | 5 | PF12796 | |
| Domain | - | 4.12e-03 | 20 | 90 | 2 | 3.30.565.10 | |
| Domain | HATPase_C | 4.54e-03 | 21 | 90 | 2 | IPR003594 | |
| Pubmed | GPI DLGAP2 ATAD3B MYH10 RAP1GAP KRT16 RTCB SACS KRT19 AMOT PPFIA2 SPTB NCKIPSD CAPZB KBTBD11 XRN1 TLN2 PLEC PRPF40A STRIP1 | 5.53e-10 | 1431 | 90 | 20 | 37142655 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RAP1GAP RTCB KRT19 AMOT BRD4 SYNE2 NCKIPSD CAPZB XRN1 ANKRD11 ANKRD26 IRS1 PLEC ABTB2 | 4.63e-08 | 861 | 90 | 14 | 36931259 |
| Pubmed | 5.82e-07 | 7 | 90 | 3 | 27782878 | ||
| Pubmed | CCNH ATAD3B MYH10 KRT16 SACS KRT19 PPFIA2 SPEF2 CNTRL SYNE2 SERF2 CEP83 CAPZB XRN1 ANKRD26 PLEC | 8.32e-07 | 1442 | 90 | 16 | 35575683 | |
| Pubmed | 9.66e-07 | 201 | 90 | 7 | 25192599 | ||
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 1.25e-06 | 411 | 90 | 9 | 35182466 | |
| Pubmed | 2.39e-06 | 147 | 90 | 6 | 16959763 | ||
| Pubmed | MEAF6 ATAD3B MYH10 RTCB SMC3 ATXN2 DHX40 SYNE2 XRN1 ANKRD28 ZFHX3 SIN3A PRPF40A LIN9 GADD45GIP1 | 3.77e-06 | 1429 | 90 | 15 | 35140242 | |
| Pubmed | 4.27e-06 | 92 | 90 | 5 | 20301317 | ||
| Pubmed | 5.32e-06 | 491 | 90 | 9 | 36273042 | ||
| Pubmed | GPI KRT16 KRT19 AMOT CNTRL KBTBD11 XRN1 ANKRD26 ANKRD28 ZFHX3 STRIP1 | 5.40e-06 | 777 | 90 | 11 | 35844135 | |
| Pubmed | 5.83e-06 | 98 | 90 | 5 | 34943047 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TRPM4 ATAD3B MYH10 DCAF8 ATXN2 PPFIA2 SPTB UVSSA CAPN1 ANKRD11 LAMA3 ZFHX3 ANKRD12 ARIH1 RBFOX2 | 6.19e-06 | 1489 | 90 | 15 | 28611215 |
| Pubmed | DNA-binding and regulation mechanisms of the SIX family of retinal determination proteins. | 6.62e-06 | 2 | 90 | 2 | 18293925 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 23022192 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 17499243 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 29797489 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 17690304 | ||
| Pubmed | Neuronal PAS Domain Proteins 1 and 3 Are Master Regulators of Neuropsychiatric Risk Genes. | 6.62e-06 | 2 | 90 | 2 | 28499489 | |
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 8.18e-06 | 182 | 90 | 6 | 32239614 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 8.79e-06 | 281 | 90 | 7 | 28706196 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | ATAD3B MYH10 SMC3 KRT19 AMOT DHX40 CAPZB ANKRD28 PKN2 PLEC ARIH1 STRIP1 | 1.10e-05 | 1005 | 90 | 12 | 19615732 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | MYH10 KRT19 DHX40 CNTRL CAPZB XRN1 ANKRD26 ANKRD28 NKAP PLEC RBFOX2 | 1.29e-05 | 853 | 90 | 11 | 28718761 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | GPI EPPK1 KRT16 RTCB SACS SMC3 AMOT SYNE2 CAPZB PLEC PRPF40A GADD45GIP1 | 1.32e-05 | 1024 | 90 | 12 | 24711643 |
| Pubmed | 1.34e-05 | 418 | 90 | 8 | 34709266 | ||
| Pubmed | DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC. | 1.44e-05 | 118 | 90 | 5 | 37105989 | |
| Pubmed | 1.54e-05 | 709 | 90 | 10 | 22988430 | ||
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 1.94e-05 | 212 | 90 | 6 | 33853758 | |
| Pubmed | FOX-2 dependent splicing of ataxin-2 transcript is affected by ataxin-1 overexpression. | 1.98e-05 | 3 | 90 | 2 | 22666429 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 11854008 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 16172381 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 15347806 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 25232867 | ||
| Pubmed | Regulatory domain selectivity in the cell-type specific PKN-dependence of cell migration. | 1.98e-05 | 3 | 90 | 2 | 21754995 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 27919031 | ||
| Pubmed | RNF38 suppress growth and metastasis via ubiquitination of ACTN4 in nasopharyngeal carcinoma. | 2.09e-05 | 62 | 90 | 4 | 35568845 | |
| Pubmed | 2.52e-05 | 222 | 90 | 6 | 37071664 | ||
| Pubmed | CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. | 2.99e-05 | 468 | 90 | 8 | 36042349 | |
| Pubmed | MEAF6 ATAD3B MLH3 DCAF8 BRD4 XRN1 ANKRD28 ZFHX3 SIN3A NKAP PRPF40A GADD45GIP1 | 3.07e-05 | 1116 | 90 | 12 | 31753913 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 3.24e-05 | 774 | 90 | 10 | 15302935 | |
| Pubmed | 3.26e-05 | 24 | 90 | 3 | 30719818 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 23147115 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 9314494 | ||
| Pubmed | STEF/TIAM2-mediated Rac1 activity at the nuclear envelope regulates the perinuclear actin cap. | 3.96e-05 | 4 | 90 | 2 | 29844364 | |
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 32232464 | ||
| Pubmed | Binding of the SARS-CoV-2 envelope E protein to human BRD4 is essential for infection. | 3.96e-05 | 4 | 90 | 2 | 35716662 | |
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 14508709 | ||
| Pubmed | 4.32e-05 | 493 | 90 | 8 | 15368895 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 4.60e-05 | 807 | 90 | 10 | 30575818 | |
| Pubmed | 4.69e-05 | 809 | 90 | 10 | 32129710 | ||
| Pubmed | 4.86e-05 | 152 | 90 | 5 | 16009940 | ||
| Pubmed | 4.91e-05 | 77 | 90 | 4 | 21525287 | ||
| Pubmed | 5.01e-05 | 653 | 90 | 9 | 22586326 | ||
| Pubmed | 5.13e-05 | 655 | 90 | 9 | 35819319 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 5.77e-05 | 665 | 90 | 9 | 30457570 | |
| Pubmed | 5.83e-05 | 29 | 90 | 3 | 28049658 | ||
| Pubmed | 5.83e-05 | 29 | 90 | 3 | 21834987 | ||
| Pubmed | 6.02e-05 | 159 | 90 | 5 | 34537242 | ||
| Pubmed | Fox-3 and PSF interact to activate neural cell-specific alternative splicing. | 6.59e-05 | 5 | 90 | 2 | 21177649 | |
| Pubmed | 6.59e-05 | 5 | 90 | 2 | 26034287 | ||
| Pubmed | 6.59e-05 | 5 | 90 | 2 | 31515271 | ||
| Pubmed | 6.88e-05 | 266 | 90 | 6 | 19380743 | ||
| Pubmed | 7.15e-05 | 31 | 90 | 3 | 27798109 | ||
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | 7.32e-05 | 269 | 90 | 6 | 29511261 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 7.57e-05 | 394 | 90 | 7 | 27248496 | |
| Pubmed | Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. | 7.92e-05 | 87 | 90 | 4 | 17148452 | |
| Pubmed | 8.10e-05 | 274 | 90 | 6 | 34244482 | ||
| Pubmed | 8.71e-05 | 403 | 90 | 7 | 30562941 | ||
| Pubmed | 9.14e-05 | 549 | 90 | 8 | 38280479 | ||
| Pubmed | Characterization of the Six1 homeobox gene in normal mammary gland morphogenesis. | 9.87e-05 | 6 | 90 | 2 | 20074369 | |
| Pubmed | 9.87e-05 | 6 | 90 | 2 | 20301283 | ||
| Pubmed | The expression profile and clinic significance of the SIX family in non-small cell lung cancer. | 9.87e-05 | 6 | 90 | 2 | 27821176 | |
| Pubmed | 9.87e-05 | 6 | 90 | 2 | 20301304 | ||
| Pubmed | 9.87e-05 | 6 | 90 | 2 | 19900183 | ||
| Pubmed | 9.87e-05 | 6 | 90 | 2 | 34610416 | ||
| Pubmed | Six2 regulates Pax9 expression, palatogenesis and craniofacial bone formation. | 9.87e-05 | 6 | 90 | 2 | 31765609 | |
| Pubmed | 9.87e-05 | 6 | 90 | 2 | 18827015 | ||
| Pubmed | 1.03e-04 | 35 | 90 | 3 | 24515614 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 1.05e-04 | 560 | 90 | 8 | 21653829 | |
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 1.06e-04 | 288 | 90 | 6 | 31501420 | |
| Pubmed | 1.08e-04 | 289 | 90 | 6 | 37132043 | ||
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 1.08e-04 | 289 | 90 | 6 | 23752268 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | CWF19L2 ZMAT5 MYH10 KRT16 RTCB SACS BRD4 CAPZB PLEC SIM1 PRPF40A | 1.11e-04 | 1082 | 90 | 11 | 38697112 |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | 1.19e-04 | 732 | 90 | 9 | 34732716 | |
| Pubmed | CCNH TRPM4 HABP4 RTCB ATXN2 DHX40 CEP83 XRN1 ANKRD11 ZFHX3 NKAP LIN9 STRIP1 | 1.24e-04 | 1497 | 90 | 13 | 31527615 | |
| Pubmed | 1.26e-04 | 98 | 90 | 4 | 18557763 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.30e-04 | 430 | 90 | 7 | 35044719 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TRPM4 EPPK1 BRD4 SREBF1 KBTBD11 ANKRD11 TLN2 IRS1 PLEC ABTB2 PKN3 | 1.33e-04 | 1105 | 90 | 11 | 35748872 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 1.36e-04 | 582 | 90 | 8 | 20467437 | |
| Pubmed | 1.38e-04 | 7 | 90 | 2 | 17074803 | ||
| Pubmed | 1.38e-04 | 7 | 90 | 2 | 22615490 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 1.53e-04 | 934 | 90 | 10 | 33916271 | |
| Pubmed | MEAF6 GPI HABP4 MYH10 SMC3 BRD4 SERF2 SREBF1 XRN1 ANKRD11 ECEL1 NKAP | 1.59e-04 | 1327 | 90 | 12 | 32694731 | |
| Pubmed | An integrated workflow for charting the human interaction proteome: insights into the PP2A system. | 1.64e-04 | 105 | 90 | 4 | 19156129 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.78e-04 | 605 | 90 | 8 | 28977666 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | MEAF6 CWF19L2 ATAD3B RTCB ATXN2 BRD4 SERF2 ANKRD11 FANCM PRPF40A | 1.81e-04 | 954 | 90 | 10 | 36373674 |
| Pubmed | Six3 and Six6 activity is modulated by members of the groucho family. | 1.84e-04 | 8 | 90 | 2 | 12441302 | |
| Pubmed | 1.84e-04 | 8 | 90 | 2 | 11321598 | ||
| Pubmed | 1.90e-04 | 109 | 90 | 4 | 29511296 | ||
| Pubmed | Characterization of the zinc-induced Shank3 interactome of mouse synaptosome. | 1.90e-04 | 109 | 90 | 4 | 29111324 | |
| Interaction | POLD1 interactions | ATG16L1 ATAD3B RTCB BRD4 CAPN1 CAPZB NKAP ARIH1 PRPF40A ITPR1 NPAS1 | 3.11e-07 | 337 | 90 | 11 | int:POLD1 |
| Interaction | VIM interactions | CWF19L2 HABP4 GCFC2 EPPK1 KRT16 RTCB SACS KRT19 SPEF2 BRD4 CAPN1 CNTRL CAPZB IRS1 PLEC | 2.55e-06 | 804 | 90 | 15 | int:VIM |
| Interaction | KCTD13 interactions | GPI DLGAP2 MYH10 RAP1GAP KRT16 RTCB SACS KRT19 AMOT PPFIA2 SPTB NCKIPSD CAPZB KBTBD11 XRN1 TLN2 PLEC ARIH1 PRPF40A STRIP1 | 2.61e-06 | 1394 | 90 | 20 | int:KCTD13 |
| Interaction | KHDRBS1 interactions | ATG16L1 ATXN2 BRD4 NCKIPSD CAPZB SREBF1 IRS1 SIN3A PLEC RBFOX2 | 6.42e-06 | 373 | 90 | 10 | int:KHDRBS1 |
| Interaction | DES interactions | 6.90e-06 | 158 | 90 | 7 | int:DES | |
| Interaction | ANKRD50 interactions | 8.90e-06 | 108 | 90 | 6 | int:ANKRD50 | |
| Interaction | FOXK1 interactions | 1.13e-05 | 238 | 90 | 8 | int:FOXK1 | |
| Interaction | PLEKHG1 interactions | 1.23e-05 | 67 | 90 | 5 | int:PLEKHG1 | |
| Interaction | SMG7 interactions | 1.28e-05 | 319 | 90 | 9 | int:SMG7 | |
| Interaction | KIF20A interactions | ATAD3B MYH10 EPPK1 RTCB BRD4 SPTB SYNE2 CAPZB XRN1 PLEC PRPF40A GADD45GIP1 PKN3 RBFOX2 ITPR1 SMTN | 1.52e-05 | 1052 | 90 | 16 | int:KIF20A |
| Interaction | SYNCRIP interactions | HABP4 GCFC2 ATXN2 BRD4 UVSSA CAPN1 CAPZB XRN1 ANKRD11 ANKRD28 TLN2 NKAP PRPF40A | 1.83e-05 | 721 | 90 | 13 | int:SYNCRIP |
| Interaction | ERC1 interactions | 2.07e-05 | 187 | 90 | 7 | int:ERC1 | |
| Interaction | CSNK2B interactions | MEAF6 CCNH ATG16L1 CWF19L2 DCAF8 BRD4 CAPZB ANKRD11 ANKRD28 IRS1 NKAP GADD45GIP1 | 2.15e-05 | 625 | 90 | 12 | int:CSNK2B |
| Interaction | PLEC interactions | 2.20e-05 | 430 | 90 | 10 | int:PLEC | |
| Interaction | NEFM interactions | 2.29e-05 | 190 | 90 | 7 | int:NEFM | |
| Interaction | KDF1 interactions | 2.45e-05 | 192 | 90 | 7 | int:KDF1 | |
| Interaction | YWHAH interactions | ATG16L1 RAP1GAP EPPK1 RTCB KRT19 AMOT BRD4 CNTRL SYNE2 NCKIPSD CAPZB XRN1 ANKRD11 ANKRD26 IRS1 PLEC | 2.68e-05 | 1102 | 90 | 16 | int:YWHAH |
| Interaction | CHD3 interactions | HABP4 ATAD3B MYH10 KRT16 RTCB SMC3 KRT19 BRD4 SERF2 ZFHX3 SIN3A PRPF40A LIN9 | 3.05e-05 | 757 | 90 | 13 | int:CHD3 |
| Interaction | CRK interactions | 4.10e-05 | 370 | 90 | 9 | int:CRK | |
| Interaction | KRT78 interactions | 4.40e-05 | 87 | 90 | 5 | int:KRT78 | |
| Interaction | N4BP2 interactions | 4.90e-05 | 89 | 90 | 5 | int:N4BP2 | |
| Interaction | KIF7 interactions | 4.92e-05 | 146 | 90 | 6 | int:KIF7 | |
| Interaction | ATXN1 interactions | MYH10 GCFC2 KRT16 RTCB ATXN2 KRT19 BRD4 SYNE2 CAPZB SREBF1 NKAP ARIH1 PRPF40A RBFOX2 STRIP1 | 5.28e-05 | 1039 | 90 | 15 | int:ATXN1 |
| Interaction | SMARCC1 interactions | 5.47e-05 | 384 | 90 | 9 | int:SMARCC1 | |
| Interaction | WWTR1 interactions | 1.12e-04 | 422 | 90 | 9 | int:WWTR1 | |
| Interaction | TRIM37 interactions | ATG16L1 CWF19L2 MYH10 EPPK1 KRT19 CAPZB XRN1 ANKRD11 ANKRD12 PLEC SMTN | 1.13e-04 | 630 | 90 | 11 | int:TRIM37 |
| Interaction | KTN1 interactions | 1.17e-04 | 331 | 90 | 8 | int:KTN1 | |
| Interaction | AR interactions | CCNH MYH10 MLH3 EPPK1 RTCB SMC3 BRD4 CAPZB SREBF1 ZFHX3 SIN3A PRPF40A LIN9 GADD45GIP1 | 1.23e-04 | 992 | 90 | 14 | int:AR |
| Interaction | PRPF38B interactions | 1.23e-04 | 108 | 90 | 5 | int:PRPF38B | |
| Interaction | INA interactions | 1.26e-04 | 173 | 90 | 6 | int:INA | |
| Interaction | KRT72 interactions | 1.40e-04 | 59 | 90 | 4 | int:KRT72 | |
| Interaction | TFCP2 interactions | 1.44e-04 | 436 | 90 | 9 | int:TFCP2 | |
| Interaction | CEP152 interactions | 1.52e-04 | 179 | 90 | 6 | int:CEP152 | |
| Interaction | H2BC4 interactions | 1.61e-04 | 259 | 90 | 7 | int:H2BC4 | |
| Interaction | KRT4 interactions | 1.70e-04 | 62 | 90 | 4 | int:KRT4 | |
| Interaction | ENTR1 interactions | 1.98e-04 | 188 | 90 | 6 | int:ENTR1 | |
| Interaction | HOXB7 interactions | 2.08e-04 | 26 | 90 | 3 | int:HOXB7 | |
| Interaction | CEP192 interactions | 2.22e-04 | 192 | 90 | 6 | int:CEP192 | |
| Interaction | GRIPAP1 interactions | 2.22e-04 | 192 | 90 | 6 | int:GRIPAP1 | |
| Interaction | BTF3 interactions | ATG16L1 ATAD3B MYH10 RTCB KRT19 BRD4 SPTB CAPZB PKN2 PLEC ITPR1 SMTN | 2.22e-04 | 799 | 90 | 12 | int:BTF3 |
| Interaction | CDK9 interactions | CCNH ATG16L1 MYH10 RTCB SMC3 KRT19 BRD4 SPTB CAPZB PLEC PRPF40A | 2.34e-04 | 685 | 90 | 11 | int:CDK9 |
| Interaction | KIAA1671 interactions | 2.34e-04 | 194 | 90 | 6 | int:KIAA1671 | |
| Interaction | DNMBP interactions | 2.35e-04 | 124 | 90 | 5 | int:DNMBP | |
| Interaction | PRMT5 interactions | 2.55e-04 | 471 | 90 | 9 | int:PRMT5 | |
| Interaction | TNRC6B interactions | 2.71e-04 | 282 | 90 | 7 | int:TNRC6B | |
| Interaction | PIBF1 interactions | 2.76e-04 | 200 | 90 | 6 | int:PIBF1 | |
| Interaction | HNRNPA1 interactions | ATG16L1 EPPK1 KRT16 RTCB ATXN2 BRD4 CAPZB XRN1 ANKRD12 PLEC PRPF40A GADD45GIP1 RBFOX2 | 2.81e-04 | 945 | 90 | 13 | int:HNRNPA1 |
| Interaction | AKR7L interactions | 3.03e-04 | 72 | 90 | 4 | int:AKR7L | |
| Interaction | TCHP interactions | 3.04e-04 | 131 | 90 | 5 | int:TCHP | |
| Interaction | ANKRD26 interactions | 3.04e-04 | 131 | 90 | 5 | int:ANKRD26 | |
| Interaction | PRPH interactions | 3.07e-04 | 204 | 90 | 6 | int:PRPH | |
| Interaction | CSNK2A1 interactions | MEAF6 GPI ATG16L1 HOXB7 GCFC2 ATXN2 BRD4 CAPZB ANKRD11 IRS1 SIN3A NKAP PRPF40A | 3.15e-04 | 956 | 90 | 13 | int:CSNK2A1 |
| Interaction | SPOP interactions | 3.46e-04 | 491 | 90 | 9 | int:SPOP | |
| Interaction | APC interactions | 3.50e-04 | 389 | 90 | 8 | int:APC | |
| Interaction | KRT23 interactions | 3.54e-04 | 31 | 90 | 3 | int:KRT23 | |
| Interaction | THOC1 interactions | 3.59e-04 | 210 | 90 | 6 | int:THOC1 | |
| Interaction | RLIM interactions | 3.69e-04 | 392 | 90 | 8 | int:RLIM | |
| Interaction | KRT6C interactions | 3.73e-04 | 76 | 90 | 4 | int:KRT6C | |
| Interaction | USP54 interactions | 3.77e-04 | 212 | 90 | 6 | int:USP54 | |
| Interaction | HDAC1 interactions | ATG16L1 MYH10 RTCB SMC3 AMOT BRD4 SYNE2 SREBF1 XRN1 ANKRD28 ZFHX3 SIN3A PLEC LIN9 | 3.83e-04 | 1108 | 90 | 14 | int:HDAC1 |
| Interaction | SGPL1 interactions | 3.87e-04 | 213 | 90 | 6 | int:SGPL1 | |
| Interaction | CCZ1 interactions | 3.92e-04 | 77 | 90 | 4 | int:CCZ1 | |
| Interaction | YWHAG interactions | ATG16L1 MYH10 RAP1GAP RTCB KRT19 AMOT SYNE2 NCKIPSD CAPZB ANKRD11 ANKRD26 PKN2 IRS1 NKAP PRPF40A | 3.95e-04 | 1248 | 90 | 15 | int:YWHAG |
| Interaction | PPFIA1 interactions | 3.96e-04 | 214 | 90 | 6 | int:PPFIA1 | |
| Interaction | BRCA1 interactions | GPI CCNH CWF19L2 MYH10 SMC3 DHX40 BRD4 CAPZB ANKRD26 ANKRD28 PLEC ARIH1 FANCM ITPR1 SMTN | 3.98e-04 | 1249 | 90 | 15 | int:BRCA1 |
| Interaction | CDC5L interactions | CWF19L2 EPPK1 RTCB SMC3 DHX40 PPFIA2 BRD4 CAPZB TLN2 PKN2 PLEC PRPF40A | 4.11e-04 | 855 | 90 | 12 | int:CDC5L |
| Interaction | CFH interactions | 4.12e-04 | 140 | 90 | 5 | int:CFH | |
| Interaction | ANKHD1 interactions | 4.16e-04 | 216 | 90 | 6 | int:ANKHD1 | |
| Interaction | GOLGA2 interactions | CCNH ATG16L1 CWF19L2 MYH10 SMC3 ANKRD11 ZFHX3 SIN3A GADD45GIP1 PKN3 STRIP1 | 4.17e-04 | 733 | 90 | 11 | int:GOLGA2 |
| Interaction | S100A4 interactions | 4.69e-04 | 144 | 90 | 5 | int:S100A4 | |
| Interaction | SIRT7 interactions | MYH10 EPPK1 RTCB BRD4 CAPN1 SYNE2 SERF2 XRN1 ANKRD28 PLEC PRPF40A | 4.72e-04 | 744 | 90 | 11 | int:SIRT7 |
| Interaction | SNX18 interactions | 4.76e-04 | 81 | 90 | 4 | int:SNX18 | |
| Interaction | PPP1R9B interactions | GPI DLGAP2 ATG16L1 MYH10 SPTB CAPZB ANKRD28 PLEC ADCY5 ITPR1 | 4.77e-04 | 626 | 90 | 10 | int:PPP1R9B |
| Interaction | SNW1 interactions | CWF19L2 EPPK1 RTCB SMC3 DHX40 BRD4 PKN2 SIN3A PLEC PRPF40A RBFOX2 | 4.88e-04 | 747 | 90 | 11 | int:SNW1 |
| Interaction | GATA4 interactions | 5.04e-04 | 411 | 90 | 8 | int:GATA4 | |
| Interaction | RPGRIP1L interactions | 5.17e-04 | 225 | 90 | 6 | int:RPGRIP1L | |
| Interaction | FOXK2 interactions | 5.17e-04 | 225 | 90 | 6 | int:FOXK2 | |
| Interaction | ANKRD17 interactions | 5.29e-04 | 226 | 90 | 6 | int:ANKRD17 | |
| Interaction | CALCOCO1 interactions | 5.46e-04 | 84 | 90 | 4 | int:CALCOCO1 | |
| Interaction | SMC1A interactions | 5.63e-04 | 418 | 90 | 8 | int:SMC1A | |
| Interaction | KRT74 interactions | 6.00e-04 | 37 | 90 | 3 | int:KRT74 | |
| Interaction | KRT82 interactions | 6.00e-04 | 37 | 90 | 3 | int:KRT82 | |
| Interaction | SMC2 interactions | 6.10e-04 | 323 | 90 | 7 | int:SMC2 | |
| Cytoband | 17q21.2 | 3.63e-04 | 70 | 90 | 3 | 17q21.2 | |
| Cytoband | 14q21.2 | 7.06e-04 | 20 | 90 | 2 | 14q21.2 | |
| Cytoband | 13q12 | 1.02e-03 | 24 | 90 | 2 | 13q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q12 | 1.21e-03 | 235 | 90 | 4 | chr22q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q23 | 2.18e-03 | 130 | 90 | 3 | chr14q23 | |
| GeneFamily | Keratins, type I | 1.07e-04 | 28 | 60 | 3 | 608 | |
| GeneFamily | SINE class homeoboxes | 1.61e-04 | 6 | 60 | 2 | 525 | |
| GeneFamily | EF-hand domain containing|Plakins | 2.99e-04 | 8 | 60 | 2 | 939 | |
| GeneFamily | C2 domain containing protein kinases | 4.79e-04 | 10 | 60 | 2 | 835 | |
| GeneFamily | Basic helix-loop-helix proteins | 4.87e-04 | 110 | 60 | 4 | 420 | |
| GeneFamily | Ankyrin repeat domain containing | 1.24e-03 | 242 | 60 | 5 | 403 | |
| GeneFamily | Transient receptor potential cation channels | 3.87e-03 | 28 | 60 | 2 | 249 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SACS SMC3 ATXN2 SYNE2 DDR2 ANKRD28 TOGARAM1 ZFHX3 PKN2 IRS1 ARIH1 DCUN1D4 RBFOX2 ITPR1 | 1.28e-06 | 856 | 90 | 14 | M4500 |
| Coexpression | BENPORATH_SUZ12_TARGETS | HOXB7 AMOT SPTB PTH2 ANKRD11 LAMA3 ZFHX3 ECEL1 PLEC FAM43B SIX2 ABTB2 NPAS1 SIX6 | 1.13e-05 | 1035 | 90 | 14 | M9898 |
| Coexpression | BENPORATH_EED_TARGETS | HOXB7 ZMAT5 ATAD3B AMOT PTH2 ZFHX3 ECEL1 PLEC SIM1 FAM43B SIX2 ABTB2 NPAS1 SIX6 | 1.46e-05 | 1059 | 90 | 14 | M7617 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | RAP1GAP DCAF8 ATXN2 UVSSA CAPN1 SYNE2 SERF2 ANKRD28 ZFHX3 IRS1 ZMYM5 ITPR1 | 2.03e-05 | 807 | 90 | 12 | M16651 |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K27ME3 | 2.52e-05 | 345 | 90 | 8 | M2009 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K27ME3 | 2.63e-05 | 347 | 90 | 8 | MM860 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K27ME3 | 4.30e-05 | 272 | 90 | 7 | M1938 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K27ME3 | 5.40e-05 | 282 | 90 | 7 | MM822 | |
| Coexpression | BENPORATH_PRC2_TARGETS | 7.90e-05 | 650 | 90 | 10 | M8448 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | CWF19L2 MYH10 RAP1GAP SMC3 BRD4 CNTRL SYNE2 CEP83 ANKRD26 UBR3 ZFHX3 C1orf74 ANKRD12 FANCM PRPF40A LIN9 ZMYM5 | 1.75e-05 | 1252 | 90 | 17 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CWF19L2 MYH10 GCFC2 SMC3 DHX40 BRD4 CNTRL SYNE2 CEP83 ANKRD26 ANKRD28 ZFHX3 FANCM DCUN1D4 PRPF40A LIN9 ZMYM5 | 1.85e-05 | 1257 | 90 | 17 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CWF19L2 MYH10 GCFC2 SMC3 DHX40 BRD4 CNTRL SYNE2 CEP83 ANKRD26 ANKRD28 ZFHX3 SIM1 FANCM DCUN1D4 PRPF40A LIN9 ZMYM5 | 3.44e-05 | 1459 | 90 | 18 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 2.68e-10 | 198 | 90 | 9 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | SMC3 BRD4 CNTRL SYNE2 ANKRD11 ANKRD26 TOGARAM1 ANKRD12 PRPF40A | 2.80e-10 | 199 | 90 | 9 | 61b1ed2db71b96157b92b7535d1955a4033098da |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 7.23e-09 | 199 | 90 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.28e-08 | 173 | 90 | 7 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 1.63e-07 | 199 | 90 | 7 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.63e-07 | 199 | 90 | 7 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 1.63e-07 | 199 | 90 | 7 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 8.96e-07 | 160 | 90 | 6 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-06 | 178 | 90 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 1.78e-06 | 180 | 90 | 6 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-06 | 185 | 90 | 6 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 188 | 90 | 6 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 2.99e-06 | 197 | 90 | 6 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-06 | 197 | 90 | 6 | 87d09f53b84af482116d3e2076eab1a9e555a2a6 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-06 | 197 | 90 | 6 | 5bf5187fcba4ccc3f83bc9e884e40ff344a3d109 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.08e-06 | 198 | 90 | 6 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.08e-06 | 198 | 90 | 6 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.17e-06 | 199 | 90 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 3.17e-06 | 199 | 90 | 6 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 90 | 6 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 90 | 6 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.90e-05 | 161 | 90 | 5 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 1.90e-05 | 161 | 90 | 5 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.33e-05 | 168 | 90 | 5 | 53a982869dbf14f6a948589be9f2f3df3b9a7e97 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-05 | 173 | 90 | 5 | e1378201b15ffb98e196ac39fe3ee4b4078953bd | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 2.68e-05 | 173 | 90 | 5 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | facs-Large_Intestine-Proximal-3m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-05 | 173 | 90 | 5 | 99532bb768ee35fed939a377acb5215d3f8904bd | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-05 | 176 | 90 | 5 | d1c4c78a6d4a4ad37912eade4b7d16ef84b9a706 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-nan|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-05 | 176 | 90 | 5 | 1dd54bfaa58541de51e5a8328651d390833bd480 | |
| ToppCell | facs-Large_Intestine-Proximal-18m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-05 | 176 | 90 | 5 | 8c2f830124b3bd7c3a483aabe060a1d202c4a409 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 3.50e-05 | 183 | 90 | 5 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-05 | 187 | 90 | 5 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.98e-05 | 188 | 90 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 3.98e-05 | 188 | 90 | 5 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-05 | 189 | 90 | 5 | fc88c51ace7d883c01617f3f9b5fab70cc91cc09 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 4.08e-05 | 189 | 90 | 5 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 191 | 90 | 5 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 191 | 90 | 5 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 191 | 90 | 5 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.40e-05 | 192 | 90 | 5 | 0bb06738e1c3ec0c044a7ee61f6cf1d4781fb53c | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1-4|World / Primary Cells by Cluster | 4.51e-05 | 193 | 90 | 5 | 2eb6e4cff4fe3ce564c1581f6f7df4834895aaa9 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.51e-05 | 193 | 90 | 5 | bd0027fa97de41ae22ff64a61c8e217496f122ca | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-05 | 195 | 90 | 5 | 717e6a66bad50e711442d71360b540789646b334 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-05 | 195 | 90 | 5 | 10774b5ce17d4edd23dbf4709b11cc87cc2b87be | |
| ToppCell | tumor_Lung-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 4.85e-05 | 196 | 90 | 5 | 5a0b5aeff7e535781ea2a4c85799bb468afcb6f8 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-05 | 197 | 90 | 5 | f4dad4423384a2a25e064c849ffccf2811573be0 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.97e-05 | 197 | 90 | 5 | 2430f31d9312338e0ca23bfc6bdb0365340860fd | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 4.97e-05 | 197 | 90 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 5.22e-05 | 199 | 90 | 5 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.22e-05 | 199 | 90 | 5 | c88a28a73f54dc571f2ff1e4b55073f83cbead2c | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-05 | 199 | 90 | 5 | c2903b1a4b91e94bbdaa909bacefe901255cf248 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 90 | 5 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.34e-05 | 200 | 90 | 5 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.34e-05 | 200 | 90 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Intermediate|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 5.34e-05 | 200 | 90 | 5 | a3fcd901cb281920f1bafdfd676399a6dc37355e | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 5.34e-05 | 200 | 90 | 5 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 90 | 5 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Vip_Itih5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.44e-05 | 114 | 90 | 4 | 9f0c8dfd740d50448a6c91a00e7bae4dfc9b3302 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.62e-04 | 135 | 90 | 4 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 1.76e-04 | 138 | 90 | 4 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT2_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-04 | 142 | 90 | 4 | 94e277f038f4006d99ff50222b0f5cf89bc3d46d | |
| ToppCell | LPS-antiTNF-Myeloid-Myeloid_granulocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.02e-04 | 143 | 90 | 4 | 4a0f26eef935fe68a1da5d319503059a8a8682dd | |
| ToppCell | LPS-antiTNF-Myeloid-Myeloid_granulocytic-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.02e-04 | 143 | 90 | 4 | 65328a0a2f3972fac596e07933e74b2ef7cceb84 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.31e-04 | 148 | 90 | 4 | afebb64365c94b9476494bffe7c364677f19c8cf | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D122|Adult / Lineage, Cell type, age group and donor | 2.31e-04 | 148 | 90 | 4 | 81a1e6fdd942a612bf523c59b8b4974f6ca1fdce | |
| ToppCell | Thalamus-Neuronal-Inhibitory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.31e-04 | 148 | 90 | 4 | 5f82e5ecacfd223020b8ee975c17d68c1fe6db38 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-04 | 151 | 90 | 4 | f4f7156b2c0cfc78fd1841e07c9915d97ced561f | |
| ToppCell | mild_COVID-19_(asymptomatic)-MAIT|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 2.62e-04 | 153 | 90 | 4 | 26852f3d8f80e102e24bcb90e24aac26fdc9a32c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.82e-04 | 156 | 90 | 4 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 2.82e-04 | 156 | 90 | 4 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Kcne4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.82e-04 | 156 | 90 | 4 | 896e2d958be0a5c62fb6eebad2dfb7e1ce69f3ad | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.89e-04 | 157 | 90 | 4 | f086753b51860e23f1275bd75e8802d2a7d7b70a | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.96e-04 | 158 | 90 | 4 | 98712ed7e8e65e8c5ff9318cf0e0a04e271a055d | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-04 | 159 | 90 | 4 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-04 | 159 | 90 | 4 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-7|TCGA-Liver / Sample_Type by Project: Shred V9 | 3.03e-04 | 159 | 90 | 4 | 70288df54adab167c0f50675128619299077db11 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.10e-04 | 160 | 90 | 4 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-04 | 160 | 90 | 4 | 7064af50fc10e3ea03badf415306222b74db0f95 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Kcne4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.18e-04 | 161 | 90 | 4 | be77e99faf653480c166305df3a4e93db76f0dcb | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-HSC/MPP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.18e-04 | 161 | 90 | 4 | 46b5d80d2d521fb69752aba4c10383e715a32002 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.18e-04 | 161 | 90 | 4 | 1e17a993126e1f2a25ee7dfbb95a74ccb2a26791 | |
| ToppCell | Influenza_Severe-gd_T|World / Disease group and Cell class | 3.18e-04 | 161 | 90 | 4 | b3cdaed4d58d57e3c5dbc904a09388f3bf949407 | |
| ToppCell | facs-Thymus-Epithelium-3m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-04 | 162 | 90 | 4 | 3dc39db0d5f6f3d7bcc312a6bce7aaeb914138d1 | |
| ToppCell | facs-Thymus-Epithelium-3m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-04 | 162 | 90 | 4 | 0a7138266054ea5954649c8b61ef93905d56b068 | |
| ToppCell | facs-Thymus-Epithelium-3m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-04 | 162 | 90 | 4 | 25323785dd33337bcefd05958a4a1a208a9ceb04 | |
| ToppCell | Basal_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 3.33e-04 | 163 | 90 | 4 | 679e25e5548d157d49a73057a3b5617dccda260f | |
| ToppCell | Severe-Lymphoid-NK-CCR7+_T|Severe / Condition, Lineage, Cell class and cell subclass | 3.33e-04 | 163 | 90 | 4 | 8f0d8c124f1569a5a6bc1db7581989f24d63cca3 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal-GABAergic_neurons|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.41e-04 | 164 | 90 | 4 | 4d7b2d0980fb4f47721fa2891151e2bd892ccb91 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 164 | 90 | 4 | b895674ed2df87db8fbfb30b7e31620945588491 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.49e-04 | 165 | 90 | 4 | 94a5211072464fc24592bb107a853ce832e816fe | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.57e-04 | 166 | 90 | 4 | 006ced12f69ef13ddcba5a3891ddc7c18c384863 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.57e-04 | 166 | 90 | 4 | ac28c8cac1e94be0c47fb862c5809c92cdaa11f3 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.57e-04 | 166 | 90 | 4 | 6bb3410e65c971acc458c472015afcec6de6e310 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.57e-04 | 166 | 90 | 4 | bcdaab49bde5beba750b76fdcc3781a3c12c4fff | |
| ToppCell | NS-critical-d_0-4-Epithelial-unknown_epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.57e-04 | 166 | 90 | 4 | dd02bbe4af609c6348dc92417254f4740f2900a8 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.57e-04 | 166 | 90 | 4 | 5e3b998d740b24f790fad37350d704ca0ea10b77 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.57e-04 | 166 | 90 | 4 | 823ec03714884cb860a1260410feac8c536b6d06 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.65e-04 | 167 | 90 | 4 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Bdnf_(Deep_layer_pyramidal_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.69e-04 | 69 | 90 | 3 | 24a480394630385ee51b1dfe1123480107a11403 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Bdnf_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.69e-04 | 69 | 90 | 3 | 1ab1d92e03a31bb1fe87f055d407a81c4d1d81b8 | |
| Drug | Flecainide acetate [54143-56-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.20e-06 | 198 | 90 | 8 | 3418_DN | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.24e-05 | 195 | 90 | 7 | 7225_DN | |
| Drug | 5211181; Down 200; 12uM; MCF7; HT_HG-U133A_EA | 1.37e-05 | 198 | 90 | 7 | 950_DN | |
| Drug | magnesium ammonium phosphate | 1.55e-05 | 2 | 90 | 2 | CID000178727 | |
| Drug | cannon | 2.08e-05 | 84 | 90 | 5 | CID003050747 | |
| Disease | platelet component distribution width | HABP4 TRPM3 ATXN2 ANKRD28 PKN2 IRS1 SIN3A PLEC SCGN LIN9 ADCY5 | 1.37e-05 | 755 | 87 | 11 | EFO_0007984 |
| Disease | sphingomyelin 14:0 measurement | 1.63e-05 | 17 | 87 | 3 | EFO_0010390 | |
| Disease | resting heart rate | 8.13e-05 | 149 | 87 | 5 | EFO_0004351 | |
| Disease | Congenital muscular hypertrophy-cerebral syndrome | 8.54e-05 | 5 | 87 | 2 | C1802395 | |
| Disease | Cornelia de Lange Syndrome 3 | 8.54e-05 | 5 | 87 | 2 | C1853099 | |
| Disease | Cornelia de Lange Syndrome 1 | 8.54e-05 | 5 | 87 | 2 | C4551851 | |
| Disease | lymphocyte count | HABP4 ZMAT5 EPPK1 ATXN2 SPEF2 SPTB HLA-DRB5 SREBF1 ANKRD11 PKN2 PLEC FAM43B ADCY5 ITPR1 | 9.30e-05 | 1464 | 87 | 14 | EFO_0004587 |
| Disease | caudate nucleus volume | 9.49e-05 | 30 | 87 | 3 | EFO_0004830 | |
| Disease | De Lange syndrome | 1.28e-04 | 6 | 87 | 2 | cv:C0270972 | |
| Disease | Neurodevelopmental Disorders | 1.69e-04 | 93 | 87 | 4 | C1535926 | |
| Disease | mean platelet volume | HABP4 TRPM3 ATXN2 SYNE2 ANKRD11 ANKRD28 IRS1 SIN3A PLEC LIN9 NLRP6 | 2.03e-04 | 1020 | 87 | 11 | EFO_0004584 |
| Disease | cardiac arrest (biomarker_via_orthology) | 2.38e-04 | 8 | 87 | 2 | DOID:0060319 (biomarker_via_orthology) | |
| Disease | cleft palate (implicated_via_orthology) | 2.38e-04 | 8 | 87 | 2 | DOID:674 (implicated_via_orthology) | |
| Disease | Cornelia De Lange Syndrome | 2.38e-04 | 8 | 87 | 2 | C0270972 | |
| Disease | Aqueductal Stenosis | 2.38e-04 | 8 | 87 | 2 | C2936786 | |
| Disease | obesity (implicated_via_orthology) | 4.46e-04 | 215 | 87 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | calcium measurement | 5.38e-04 | 628 | 87 | 8 | EFO_0004838 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 5.56e-04 | 12 | 87 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | Anemia, Hemolytic, Acquired | 6.56e-04 | 13 | 87 | 2 | C0002879 | |
| Disease | Anemia, Hemolytic | 6.56e-04 | 13 | 87 | 2 | C0002878 | |
| Disease | Anemia, Microangiopathic | 6.56e-04 | 13 | 87 | 2 | C0002889 | |
| Disease | Microangiopathic hemolytic anemia | 6.56e-04 | 13 | 87 | 2 | C0221021 | |
| Disease | thyroid gland papillary carcinoma (is_marker_for) | 7.64e-04 | 14 | 87 | 2 | DOID:3969 (is_marker_for) | |
| Disease | fourth ventricle volume measurement | 1.00e-03 | 16 | 87 | 2 | EFO_0010303 | |
| Disease | susceptibility to strep throat measurement | 1.49e-03 | 76 | 87 | 3 | EFO_0008408 | |
| Disease | heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease, cancer | 1.58e-03 | 20 | 87 | 2 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004352, MONDO_0004992 | |
| Disease | myeloid white cell count | 1.77e-03 | 937 | 87 | 9 | EFO_0007988 | |
| Disease | blood phosphate measurement | 1.78e-03 | 174 | 87 | 4 | EFO_0010972 | |
| Disease | urate measurement, bone density | 2.37e-03 | 619 | 87 | 7 | EFO_0003923, EFO_0004531 | |
| Disease | mean fractional anisotropy measurement | 2.82e-03 | 95 | 87 | 3 | EFO_0008399 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FDFAREKDQRSLDIN | 201 | Q92564 | |
| DFNRDLRERLETANK | 506 | Q4VCS5 | |
| EAERFSRKAAQAARD | 1021 | Q7Z7A1 | |
| SRKAAQAARDLTRAE | 1026 | Q7Z7A1 | |
| EEQLARLRADANRKF | 16 | P51946 | |
| QGDENKSVRDRFNAR | 2571 | Q6UB99 | |
| SDSFEQFRRAAREKE | 1221 | O60885 | |
| EANRLNAENEKDSRR | 201 | Q676U5 | |
| SRGANINAFDKKDRR | 161 | O15084 | |
| DLRTRFRTQNDFADL | 241 | Q96LT6 | |
| KRAASFRQNSASERA | 1026 | Q9P1A6 | |
| RNFRSQAEKAQLEAE | 511 | Q9Y592 | |
| KDVAAHFLARERRND | 1046 | O95622 | |
| DDSKTSVRDRFNARQ | 1971 | Q6UB98 | |
| SKRELELAFQRARDE | 1026 | Q9UPS8 | |
| KRDFFLANASRARSE | 461 | P07384 | |
| ARLRKLEVEANNAFD | 91 | P47756 | |
| TFENSADADRAREKL | 166 | O43251 | |
| RNAARSRRGKENLEF | 51 | Q99742 | |
| QNDNARLTADDFRLK | 161 | Q7Z3Y9 | |
| DAKAARDAQERSRAA | 396 | Q9Y4X5 | |
| KLDRQQDSAARDRTD | 121 | Q6IWH7 | |
| DNARLAADDFRTKFE | 156 | P08727 | |
| RNSKRSRLFSDEDDR | 56 | Q5TKA1 | |
| ALADEADRARAKARA | 276 | Q9HAY2 | |
| NSQKDFLEDRRAAVD | 91 | Q30154 | |
| RNRNFGKHLREAEAD | 1981 | Q16787 | |
| DQDASRSRLRNAQEK | 336 | Q14643 | |
| RADANKNARNDFLKE | 611 | Q16832 | |
| DAFRDKTDAQRTFRE | 46 | Q8TD08 | |
| SEEFLKREARANQLA | 431 | Q99700 | |
| AFSDFKRLQRQSDAR | 201 | Q6ZT52 | |
| RDANSFKSRDQRGVQ | 1196 | Q8IYD8 | |
| QQLQRKRRDEAAAAA | 51 | Q5JVS0 | |
| RDSEATRKNTNDAFL | 426 | Q9UHC1 | |
| RNARAEVLRQAKANF | 26 | Q2TBE0 | |
| KRANRDQDSSDDERA | 121 | Q5TAQ9 | |
| QIDNARLAADDFRTK | 191 | P08779 | |
| RSELNLRRLFDANKD | 21 | P06744 | |
| SLDRRAAELRLADNF | 56 | Q9BTN0 | |
| AASAADLDNRFRKRT | 511 | P35568 | |
| ERKAFARAARFLAAN | 101 | O95672 | |
| FNSLLEKAEARERER | 721 | O75400 | |
| KEQRDSDLAAESNFR | 111 | P09629 | |
| QAARRKRELARAQDD | 141 | P16383 | |
| DRRNRKFKEAERLFS | 76 | Q9HAF1 | |
| AQADKERRARLQAEA | 146 | Q8TAE8 | |
| RRNDDKSISDARARF | 746 | Q8IX18 | |
| FDRNKDGRLDLNDLA | 161 | O76038 | |
| RLEKQAFLDQNADRA | 4361 | Q9NZJ4 | |
| ANASRRKLQRELDDA | 1896 | P35580 | |
| KRADARDVAAQLQER | 86 | P59044 | |
| RRLDESDDKNFRRGS | 1181 | O75334 | |
| ADEKRALASFNQEER | 376 | Q8N5F7 | |
| ALASFNQEERRKREN | 381 | Q8N5F7 | |
| SRRTQDRKALAEAQA | 206 | Q6P5Z2 | |
| RAKSRRNLDFQDVLD | 436 | Q9Y3I0 | |
| RRLKDFQDALDREAA | 376 | Q9C093 | |
| FQDTNARSLAERKRE | 146 | Q2YD98 | |
| EKSRQLRDAQQDARD | 251 | Q9UQE7 | |
| RSNKDNLREAFRIAE | 236 | Q8WXH0 | |
| AAAAARRQEQTLRDA | 4761 | P58107 | |
| RAETAAQRAEALKDF | 551 | P47736 | |
| GKAREFNRNQRKDSE | 46 | Q5VSL9 | |
| RRDDGLSAAARKQRD | 26 | P84101 | |
| KNAARTRREKENSEF | 6 | P81133 | |
| FKNRRQRDRAAAAKN | 176 | O95475 | |
| SRLSAEEQAKFRLDN | 641 | Q96ST3 | |
| SRDAARSRRGKENFE | 56 | Q8IXF0 | |
| RKALSEAQARFNESS | 251 | Q16513 | |
| SAAKRQRLNELRDAA | 241 | O94819 | |
| FADLARRKDDAQQRS | 386 | Q9NZQ3 | |
| RKQADLDLARGDFAQ | 586 | P36956 | |
| RLDARAATEKFNQDL | 476 | Q8N961 | |
| TEARARAKAERENAD | 191 | Q5T9A4 | |
| DREQNNDALEKSLRR | 1856 | A4UGR9 | |
| SAADKAEEFRRQQAD | 361 | Q9NQW7 | |
| KDDRFNSSNDERIRV | 1231 | Q9HCF6 | |
| RSLALADDAAFRERA | 61 | Q96A98 | |
| ADDAAFRERARLLAA | 66 | Q96A98 | |
| QQRGRRFRSAKEAED | 96 | Q8IZH2 | |
| DNDNSSARLFERSRI | 31 | P11277 | |
| QAKARQAEAAERSRL | 1571 | Q15149 | |
| RAQARAEEDAQRFRK | 2531 | Q15149 | |
| RQRDRAAEAKERENN | 176 | Q9NPC8 | |
| LTASENRKRNAFREE | 426 | Q9UJ78 | |
| ARERQQKLLAEFASR | 1186 | Q6ZT12 | |
| FRDAAAILLDEQNKR | 41 | Q9UDW3 | |
| DFSEDNRNKCRIATA | 1551 | Q9Y4G6 | |
| RASDNLVRAAQKAAF | 2466 | Q9Y4G6 | |
| DSKRRVRQAALEAFA | 521 | Q9Y4F4 | |
| ANELNARRRSFTAAD | 101 | Q8N2U9 | |
| EEALASKRFRAERQD | 46 | P53814 | |
| NFLLARARDKRESDS | 1131 | Q8TD43 | |
| RRLDFADESANKDNA | 586 | Q15911 |